PACB icon

Pacific Biosciences
PACB

Overview Fund Activity

106 hedge funds and large institutions have $406M invested in Pacific Biosciences in 2017 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 32 increasing their positions, 33 reducing their positions, and 22 closing their positions.

Holders
106
Holders Change
-9
Holders Change %
-7.83%
% of All Funds
2.64%
Holding in Top 10
3
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+200%
% of All Funds
0.07%
New
19
Increased
32
Reduced
33
Closed
22
Calls
$244K
Puts
$4.1M
Net Calls
-$3.85M
Net Calls Change
-$1.67M

Top Buyers

1
Credit Agricole
1
Credit Agricole
France
$77.8M
2
BlackRock
2
BlackRock
New York
$41.4M
3
RCM
3
Raging Capital Management
New Jersey
$25.5M
4
GGHC
4
Gilder Gagnon Howe & Co
New York
$18.7M
5
Point72 Asset Management
5
Point72 Asset Management
Connecticut
$6.61M

Top Sellers

1
UBS Group
1
UBS Group
Switzerland
$586K
2
Lord, Abbett & Co
2
Lord, Abbett & Co
New Jersey
$4.59M
3
Millennium Management
3
Millennium Management
New York
$85K
4
LCS
4
Levin Capital Strategies
New York
$0
5
Alyeska Investment Group
5
Alyeska Investment Group
Illinois
$0
Name Market Value Shares Shares
Change 		Shares
Change %
Simplex Trading
126
Simplex Trading
Illinois
– – -2,516 Closed
Nisa Investment Advisors
127
Nisa Investment Advisors
Missouri
– – -1,700 Closed
LOAMU
128
Lombard Odier Asset Management (USA)
New York
– – – –
ST
129
Spot Trading
Illinois
– – – –
MAM
130
Meeder Asset Management
Ohio
$0 83 +83 New
2 3 4 5
6